Bayer Aktiengesellschaft

Bayer Aktiengesellschaft

BAYN.DE

€49.00

Updated: 24/09/2026, 10:36:19

Market Cap
€48.14B
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
DE
Stock valuation chart
One-year closing share-price history for BAYN.DE
Company Profile

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

EUR
XETRA
CEO: Bill Anderson
Employees: 87,830
https://www.bayer.com
Asset Summaries
Latest generated summaries for BAYN.DE

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for BAYN.DE.
Share price
€49.00
Market cap
€48.14B
Exchange
XETRA
Currency
EUR
CEO
Bill Anderson
Employees
87,830
IPO date
16/12/1996
Beta
0.834
Last dividend
€0.00
Day range
€49.00 – €49.74
52-week range
€25.78 – €53.92
1-day performance
-0.63%
1-year performance
90.07%
Current drawdown (1Y)
-9.12%
CIK
N/A
CUSIP
D0712D163
ISIN
DE000BAY0017
Created
07/09/2026, 05:15:17
Last update
24/09/2026, 10:36:19

Track Bayer Aktiengesellschaft with an AI analyst

See which prediction-market events move BAYN.DE, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to BAYN.DE from your Railway `news_articles` table.

No news found for this symbol.